Situacea Met Tablets 50/500

Situacea Met combines Sitagliptin Phosphate and Metformin Hydrochloride in a powerful oral tablet designed for effective blood sugar control in type 2 diabetes. Each film-coated tablet contains 50mg of Sitagliptin and 500mg of Metformin, ensuring dual action for better glycemic management. Manufactured by a trusted pharmaceutical company, this medication is suitable for daily use as prescribed by healthcare professionals.